Concerned about COVID-19 symptoms or exposure? Need a test for school, work, or travel? CareCentral can help.
Now offering the Abbott Rapid Molecular COVID-19 test!
This Rapid Molecular test offers same-day results and improved accuracy. It is 98% accurate WHEN you are having symptoms or have had direct exposure.
- If you have not had symptoms or exposure, the test may not be as accurate, and the manufacturer advises to have a secondary molecular test done.
- This Rapid Molecular test may not be considered sufficient for international travel. Check with your airline for specific information.
- Some insurances do not cover the full cost of the Rapid Molecular tests so there may be an additional fee. Please contact your insurance company to see if you meet criteria for covered tests.
Learn more about the Abbott Rapid Molecular Test
We also perform Rapid Antigen and Lab-Based PCR testing.
Rapid Antigen offer results in under 20 minutes. The following insurances will cover for Rapid Antigen testing if patient meets testing criteria: BCBS, GIC-Unicare, Tri-Care, Tufts Carelink (Cigna), Harvard Pilgrim, and Medicare. All other patients seeking a rapid test will have to pay $160 fee.
*Rapid antigen test may have a higher false negative. Not to be confused with the PCR Molecular test.
How to get tested
Online reservations are required:
Once you register online, we’ll reserve your place in line for COVID testing – until your estimated visit time. Wait times may vary, and are expected to be longer due to high patient volume. Wait times for testing could be up to 2 hours, but we are working hard to get everyone tested in a timely and efficient manner.
COVID-19 Antibody Tests
We also offer antibody tests to check for a past infection and potential immunity. If you believe you previously had the virus, and are now symptom-free, call us for a serological test. Antibody tests are performed in-office through a simple blood draw. We will ask you a series of questions to ensure you have no current symptoms of COVID-19 and that it is safe for you to be in the building.
COVID-19 is a new virus strain that has only spread in people since December 2019. It belongs to the same family of virus as the common cold, SARS and MERS. However, it seems to be more contagious than these related coronaviruses. According to current evidence, COVID-19 virus primarily spreads through airborne respiratory droplets, close contact, and contaminated surfaces.
Reported cases of COVID-19 range from mild illness to severe pneumonia that requires hospitalization. Older adults and immunosuppressed persons are at higher risk of complications. Some carriers experience no symptoms at all.
People with COVID-19 should receive supportive care to help relieve symptoms. The Food and Drug Administration (FDA) has approved one drug, remdesivir (Veklury), to treat COVID-19 in certain situations.
There are now authorized and recommended COVID-19 vaccines in the United States, though supplies are limited. Vaccine production and availability is expected to increase over the spring. Until a greater percentage of the population can be vaccinated against COVID-19, we must continue to use mitigation measures. Testing, quarantines, and social distancing can help slow the spread of this pandemic.
- Shortness of breath or difficulty breathing
- Repeated shaking with chills
- Muscle pain
- Sore throat
- New loss of taste or smell